Current Firm
Celesta (fka WRVI)
Focus
AI, Biotech
Michael Marks brings a rare operator-to-investor background, having built Flextronics from a small contract manufacturer into a global electronics giant with tens of billions in revenue, then repeatedly stepped out of investor roles to serve as CEO or chairman at portfolio companies like Katerra rather than remaining a passive board member. His deep manufacturing and supply-chain experience from leading global operations gives him a distinctive lens for evaluating complex, asset-heavy industrial technologies that differentiates him from investors whose backgrounds are primarily in software or banking.
Michael Marks is a Founding Managing Partner, Celesta (fka WRVI) at Celesta (fka WRVI), based in Palo Alto, CA.
Michael's investment focus spans AI, Biotech, Deeptech, primarily investing at the Pre-Seed, Seed, Series A, Series B+ stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Michael Marks is a Founding Managing Partner, Celesta (fka WRVI) at Celesta (fka WRVI), based in Palo Alto, CA. Their investment focus includes AI, Biotech, Deeptech.
Michael Marks focuses on investments in AI, Biotech, Deeptech through Celesta (fka WRVI). These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Michael Marks is currently at Celesta (fka WRVI), headquartered in Palo Alto, CA, serving as Founding Managing Partner, Celesta (fka WRVI).